Zweden: Risico op hersentumor neemt toe met gebruiksduur en beluren.

dinsdag, 22 februari 2011 - Categorie: Onderzoeken

Het risico op hersentumoren neemt toe in verhouding met het aantal jaren dat men belt (met mobiele telefoon of draadloze huistelefoon) en met het cumulatieve aantal beluren, vooral bij personen die al vanaf hun tienerjaren bellen:

Bron: International Journal of Oncology 17 Feb 2011

Pooled analysis of case-control studies on malignant brain tumours and the use of mobile and cordless phones including living and deceased subjects.

Hardell L, Carlberg M, Hansson Mild K.

Department of Oncology, University Hospital, SE-701 85, Sweden.

Abstract
We studied the association between use of mobile and cordless phones and malignant brain tumours. Pooled analysis was performed of two case-control studies on patients with malignant brain tumours diagnosed during 1997-2003 and matched controls alive at the time of study inclusion and one case-control study on deceased patients and controls diagnosed during the same time period.

Cases and controls or relatives to deceased subjects were interviewed using a structured questionnaire. Replies were obtained for 1,251 (85%) cases and 2,438 (84%) controls.

The risk increased with latency period and cumulative use in hours for both mobile and cordless phones. Highest risk was found for the most common type of glioma, astrocytoma, yielding in the >10 year latency group for mobile phone use odds ratio (OR) = 2.7, 95% confidence interval (CI) = 1.9-3.7 and cordless phone use OR = 1.8, 95% CI = 1.2-2.9. In a separate analysis, these phone types were independent risk factors for glioma. The risk for astrocytoma was highest in the group with first use of a wireless phone before the age of 20; mobile phone use OR = 4.9, 95% CI = 2.2-11, cordless phone use OR = 3.9, 95% CI = 1.7-8.7.

In conclusion, an increased risk was found for glioma and use of mobile or cordless phone. The risk increased with latency time and cumulative use in hours and was highest in subjects with first use before the age of 20.

PMID: 21331446

Voor het originele abstract zie:
www.ncbi.nlm.nih.gov/pubmed/21331446?dopt=Abstract .



Lees verder in de categorie Onderzoeken | Terug naar homepage | Lees de introductie